Cargando…
Trends in Inpatient Chemotherapy Hospitalizations, Cost and Mortality for Patients with Acute Leukemias and Myeloma
Autores principales: | Gil, Kellen, Abbasi, Saqib, Mehta, Kathan, McClune, Brian, Sborov, Douglas, Ahmed, Nausheen, Abdallah, Al-Ola, Ganguly, Siddhartha, McGuirk, Joseph, Shune, Leyla, Mohyuddin, Ghulam Rehman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358787/ https://www.ncbi.nlm.nih.gov/pubmed/35950203 http://dx.doi.org/10.1007/s44228-022-00003-9 |
Ejemplares similares
-
Hospitalization at the end of life in patients with multiple myeloma
por: Abbasi, Saqib, et al.
Publicado: (2021) -
Infection risks in multiple myeloma: a systematic review and meta-analysis of randomized trials from 2015 to 2019
por: Balmaceda, Nicole, et al.
Publicado: (2021) -
Outcomes of VDPACE with an immunomodulatory agent as a salvage therapy in relapsed/refractory multiple myeloma with extramedullary disease
por: Abdallah, Al‐Ola, et al.
Publicado: (2021) -
“Waitlist mortality” is high for myeloma patients with limited access to BCMA therapy
por: Ahmed, Nausheen, et al.
Publicado: (2023) -
Toxicity management strategies for next-generation novel therapeutics
in multiple myeloma
por: Steinbach, Mary, et al.
Publicado: (2022)